
Rawmax Pharmaceutical Private Limited
About Rawmax Pharmaceutical Private Limited
Data last updated:
Rawmax Pharmaceutical Private Limited was a private limited company based in Nagpur, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2015.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2015PTC264624. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Umesh Kisanrao Wadekar and Sanjay Bechan Chourasia.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at H No 4485/193 Kashi Nagar Rameshwari Road, Nagpur, Maharashtra, India – 440027.
As per the financials filed for FY 2017, the company reported a revenue of ₹9.47 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹6.78 Lakh (net margin -71.6%) and EBITDA of -₹6.66 Lakh (EBITDA margin -70.3%).
Court records list 1 case involving the company, including 1 filed against it.
Company details
Contact details
Rawmax Pharmaceutical Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No 4485/193 Kashi Nagar Rameshwari Road, Nagpur, Maharashtra, India – 440027
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rawmax Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rawmax Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rawmax Pharmaceutical Private Limited, buy the company report.
Financials of Rawmax Pharmaceutical Private Limited
FY 2017 filings availableRawmax Pharmaceutical Private Limited reported revenue of ₹9.47 Lakh (up 29% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 29% in the latest year. EBITDA rose 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹9.47 Lakh | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹6.66 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹6.78 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -70.3% | |
| Net Profit Margin | -71.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rawmax Pharmaceutical Private Limited, buy the company report.
Board of directors of Rawmax Pharmaceutical Private Limited
Rawmax Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Kisanrao Wadekar | Director | 19 May 2015 | 11 Years 5 Months | As last reported |
| Sanjay Bechan Chourasia | Director | 07 Oct 2015 | 11 Years 1 Months | As last reported |
Peer comparison
Rawmax Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Himalayanhike India Private Limited | ₹9.48 Lakh (FY 2020) | -2.0% | Varanasi, Uttar Pradesh, India | |||
| Pardi Renuka Farmer Producer Company Limited | ₹9.48 Lakh (FY 2025) | 16.0% | Nanded, Maharashtra, India | |||
| Mystiq Yoga-Science Private Limited | ₹9.48 Lakh (FY 2024) | -24.0% | Gondal, Gujarat, India | |||
| Maxx Trading India Private Limited | ₹9.47 Lakh (FY 2025) | 95881.0% | Akbarpur, Uttar Pradesh, India | |||
| Island Sea Foods Private Limited | ₹9.47 Lakh (FY 2016) | -34.0% | Ernakulam, Kerala, India | |||
| Rawmax Pharmaceutical Private Limitedthis company | ₹9.47 Lakh (FY 2017) | -₹6.78 Lakh | -71.6% | 29.0% | Nagpur, Maharashtra, India | |
| Panvas Healthcare Private Limited | ₹9.47 Lakh (FY 2016) | -30.0% | Junnar, Maharashtra, India | |||
| Vridhi Trexim Private Limited | ₹9.47 Lakh (FY 2025) | -13.0% | Kolkata, West Bengal, India | |||
| Prabhati Agri. & Bio Energies Private Limited | ₹9.47 Lakh (FY 2025) | -77.0% | Rudrapur, Uttarakhand, India | |||
| Baburam Steel Traders Private Limited | ₹9.47 Lakh (FY 2025) | -8.0% | Kolkata, West Bengal, India | |||
| LLG Ispat Private Limited | ₹9.46 Lakh (FY 2022) | -99.0% | Delhi, India |
To see the full peer comparison of Rawmax Pharmaceutical Private Limited, buy the company report.
Auditor
Rawmax Pharmaceutical Private Limited is audited by D. N. Tonpe & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. N. Tonpe & CO. | FY 2017 | 031450 |
Shareholding
The shareholding of Rawmax Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rawmax Pharmaceutical Private Limited, buy the company report.
Legal cases
Rawmax Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Bijis Hotels (India) Pvt.Ltd.,Lonavala Through Director Mr.Harish Gopal Amin | Disposed |
To see the full case history of Rawmax Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rawmax Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rawmax Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rawmax Pharmaceutical Private Limited, buy the company report.
Recent activity
Rawmax Pharmaceutical Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Kamalkumar Nityanand Rawat ceased to be Director on 01 Feb 2022.
Frequently asked questions
Rawmax Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Rawmax Pharmaceutical was a private limited company based in Nagpur, Maharashtra, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2015 and is registered under CIN U51101MH2015PTC264624. The company has been struck off by the Registrar of Companies and is no longer operational.
Rawmax Pharmaceutical had 2 directors:
- Umesh Kisanrao Wadekar - Director
- Sanjay Bechan Chourasia - Director
The CIN (Corporate Identification Number) of Rawmax Pharmaceutical is U51101MH2015PTC264624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Rawmax Pharmaceutical is at H No 4485193 Kashi Nagar Rameshwari Road, Nagpur, Maharashtra, India – 440027.
Rawmax Pharmaceutical was incorporated on 19 May 2015. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Rawmax Pharmaceutical on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from FY 2016 are in the company report.
No. Rawmax Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
Rawmax Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Rawmax Pharmaceutical by revenue are Himalayanhike India Private Limited, Pardi Renuka Farmer Producer Company Limited, Mystiq Yoga-Science Private Limited, Maxx Trading India Private Limited, Island Sea Foods Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rawmax Pharmaceutical has 1 court case on record: 1 filed against it.

